NCT06715761 Effectiveness of Manual and Instrumental Myofascial Release in Chronic Low Back Pain and the Posture of Practitioners CrossFit®
| NCT ID | NCT06715761 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gabriela Souza de Vasconcelos |
| Condition | Low Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 51 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 51 participants in total. It began in 2024-11-01 with a primary completion date of 2025-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: Chronic low back pain (LBP) can lead to major functional disabilities and force people to take time off work, sports or leisure activities. Regular physical exercise is an important ally in reducing the risk factors for most diseases, and CrossFit® is one of the modalities that has been gaining momentum when choosing an exercise. However, the intensity recommended in training can collaborate with the development of musculoskeletal problems such as pain and postural changes, interfering with the development of the practice, with low back pain being one of the most common disorders in these practitioners, especially caused by mechanical stress. Considering that CrossFit® practitioners have already incorporated physical exercise into their routine, passive techniques such as myofascial release (ML) have been discussed as a form of treatment for LBP. For this reason, this study was designed to verify the efficacy of ML in the LBP of CrossFit® practitioners, comprising two techniques, one manual and one instrumental, and to see if the outcome of the LBP alters the posture of the spine. This is a randomised controlled clinical that will be conducted in a CrossFit® box in the city of Goiânia-GO, Brazil. At least 51 people will take part who have been doing CrossFit® for at least 3 months, who have LBP, are aged between 18-59 and are not undergoing any other treatment for low back pain. There will be two experimental groups, one that will receive manual MR and the other, cupping therapy, as well as a control group that will not receive any technique. The sessions will take place twice a week for 8 weeks. The primary outcome will be low back pain intensity, assessed at baseline, weekly and after 8 weeks, and the secondary outcomes, which will be postural deviations, spinal mobility and history of musculoskeletal pain, assessed at baseline and at the end of 8 weeks. There will be no blinding between therapist and participants. Discussion: This study will investigate whether MR is effective in relation to LBP, given that some results have already shown positive responses in acute conditions, while also verifying the repercussions on the postural aspect. The results could provide additional knowledge about the best technique to use and, having applicability to our outcomes, will favour and simplify treatment, helping professionals to make clinical decisions.
Eligibility Criteria
Inclusion Criteria: * men and women aged between 18 and 59 years; * presence of low back pain for at least 12 weeks; * have started regular CrossFit® activity at least 3 months ago. Exclusion Criteria: * perform other physical activity than CrossFit®; * continuous use of painkillers; * previous pathologies or spinal surgery; * amputations; * haematological disorders; * fibromyalgia; * hypersensitivity or skin lesions.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06715761 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 59 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06715761 currently recruiting?
Yes, NCT06715761 is actively recruiting participants. Contact the research team at gabriela_vasconcelos@ufg.br for enrollment information.
Where is the NCT06715761 trial being conducted?
This trial is being conducted at Goiânia, Brazil.
Who is sponsoring the NCT06715761 clinical trial?
NCT06715761 is sponsored by Gabriela Souza de Vasconcelos. The trial plans to enroll 51 participants.